EUVIMEDEUVIMED entdecken
Crossref

Mitochondrial‐Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy

Biyu Zhou, Nana Feng, Jian Xiao, Qingqing Huang, Qiushi Li, Zhanzhan Zhang iD, Yang Liu iD

Advanced Healthcare Materials · 2026-05 · 15 (18)

DOI: 10.1002/adhm.71003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.03.2026. Verfasst von Biyu Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medicinal Chemical Biology, College of Chemistry, Key Laboratory of Functional Polymer Materials Ministry of Education, Nanka…. Hauptthemen laut MEDLINE: Pyroptosis, Nanoparticles, Antimicrobial Peptides, Immunotherapy. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Tianjin Science Foundation for Distinguished Young Scholars, the Key Projects of Tianjin Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer immunotherapy is limited by the intrinsically low immunogenicity of tumors, which restricts T cell activation and reduces therapeutic efficacy. Pyroptosis, a proinflammatory form of programmed cell death (PCD), provides a strategy to overcome this limitation by releasing damage‐associated molecular patterns (DAMPs) and cytokines that coactivate innate and adaptive immunity. An antimicrobial peptide (AMP)‐based pyroptosis inducer (API) is developed to selectively disrupt mitochondrial homeostasis and trigger potent cytotoxic T cell responses. API consists of amphiphilic copolymers p(PPE m ‐ co ‐AMP n ), in which AMPs are clustered on nanoparticle surfaces to facilitate cellular uptake. Upon exposure to intracellular reactive oxygen species (ROS), phenylboronic pinacol ester (PPE) linkages are cleaved, leading to nanoparticle disassembly into linear polymers. This transition restores the membrane‐lytic activity of AMPs, enabling selective mitochondrial disruption and efficient pyroptosis. Using the model peptide (KLAKLAK) 2 , API induces mitochondrial lysis and pyroptotic cell death, eliciting strong T cell activation. In a 4T1 breast cancer model, API treatment markedly suppresses tumor growth, metastasis, and recurrence without systemic toxicity. These results demonstrate API as a versatile nanoplatform for precise pyroptosis induction and highlight its promise for enhancing breast cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisNanoparticlesAntimicrobial PeptidesImmunotherapyMitochondriaBreast NeoplasmsAnimalsFemaleMiceCell Line, TumorHumansMice, Inbred BALB CReactive Oxygen Species

Stichwörter der Autor:innen

antimicrobial peptidebreast cancer immunotherapymitochondrialmorphological transitionpyroptosis

Substanzen

Antimicrobial PeptidesReactive Oxygen Species

Autor:innen und Institutionen

  • State Key Laboratory of Medicinal Chemical Biology, College of Chemistry, Key Laboratory of Functional Polymer Materials Ministry of Education, Nankai University, Tianjin, China.
  • School of Medical Imaging, Tianjin Medical University, Tianjin, China.
  • Frontiers Science Center for New Organic Matter, Nankai University, Tianjin, China.
  • Academy for Advanced Interdisciplinary Studies, Nankai University, Tianjin, China.

ORCID-Profile: Zhanzhan Zhang, Yang Liu

Förderung

  • National Natural Science Foundation of China
  • Tianjin Science Foundation for Distinguished Young Scholars
  • the Key Projects of Tianjin Science and Technology
  • Academy for Advanced Interdisciplinary Studies, Nankai University (AAIS, NKU)
  • Frontiers Science Center for New Organic Matter, Nankai University

Zitieren

APA

Zhou, B., Feng, N., Xiao, J., Huang, Q., Li, Q., Zhang, Z., & Liu, Y. (2026). Mitochondrial‐Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy. Advanced Healthcare Materials, 15(18). https://doi.org/10.1002/adhm.71003

Vancouver

Zhou B, Feng N, Xiao J, Huang Q, Li Q, Zhang Z, et al. Mitochondrial‐Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy. Advanced Healthcare Materials. 2026;15(18). doi:10.1002/adhm.71003

BibTeX
@article{Zhou2026,
  author = {Zhou, Biyu and Feng, Nana and Xiao, Jian and Huang, Qingqing and Li, Qiushi and Zhang, Zhanzhan and Liu, Yang},
  title = {Mitochondrial‐Disrupting Antimicrobial Peptide Nanoparticles as Precise Pyroptosis Inducers for Breast Cancer Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {18},
  doi = {10.1002/adhm.71003}
}
Kostenlos starten →